市場調查報告書
商品編碼
1007416

前列腺癌症診斷的全球市場 - 預測:各類型,各終端用戶,各地區,企業分析

Prostate Cancer Diagnostics Market Global Forecast By Type (Preliminary Screening, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users, Regions, Company Analysis

出版日期: | 出版商: Renub Research | 英文 280 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球前列腺癌症診斷市場預計將從2020年的16億美元,到2027年達到75億美元,2020年∼2027年預測將以年複合成長率24.69%的兩位數成長。

本報告提供全球前列腺癌症診斷市場相關調查分析,提供類型,終端用戶,地區,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 市場動態

  • 成長促進因素
  • 課題

第5章 全球前列腺癌症診斷市場

第6章 市場佔有率分析

  • 診斷類型
  • 確認檢驗
  • 終端用戶
  • 地區

第7章 診斷類型 - 全球前列腺癌症診斷市場

  • 預備篩檢檢驗
  • 確認檢驗
  • PCA3
  • 經直腸超音波
  • 切片檢查

第8章 終端用戶 - 全球前列腺癌症診斷市場

  • 醫院·診所
  • 診斷中心
  • 研究機關
  • 其他

第9章 地區 - 全球前列腺癌症診斷市場

  • 北美·南美
    • 美國
    • 加拿大
    • 其他美國
  • 歐洲
    • 挪威
    • 義大利
    • 波蘭
    • 德國
    • 英國
    • 其他的歐洲
  • 亞洲
    • 中國
    • 印度
    • 其他亞洲
  • 非洲
    • 南非
    • 其他非洲國家

第10章 企業分析

  • GSK
  • AstraZeneca
  • Sanofi
  • Abbott
  • Pfizer
目錄

Early detection and treatment that improves survival chances is a paradigm in cancer treatment. Cancer, especially prostate cancer, has impacted more to men than women as their percentage was much lesser than men. Our study investigated that, Prostate cancer is the 2nd most common cancer in men across developed countries to date. At the same time incidences rate has also surged over time. According to the Renub Research report, Global Prostate Cancer Diagnostics Market will be US$ 7.5 Billion by 2027.

In earlier times, prostate cancer has been diagnosed with DRE, i.e Digital Rectal Examination and PSA blood test, most commonly called Prostate-specific antigen and TRUS, known as Transrectal Ultrasound-guided biopsy. TRUS is the golden standard examination to confirm the diagnosis in all clinical circumstances in today's time. The Diagnostics Market Size for Prostate Cancer World over was US$ 1.6 Billion in 2020.

The most important factor of prostate cancer is age and is rare under the age of 40, and its incidence rate would rise with age. Thus, the factors that are fuelling this market growth are the ageing population and the high prevalence rate of prostate cancer. However, low successes of clinical trials and high costs of drugs are the challenges facing this market. In the year 2019, as per the World Population Ageing report, 703 million people are aged 65 years worldwide. It is expected to get doubled by 2050 and reach 1.5 Billion. Around the nations, several majors have taken by the government and regulatory bodies to overcome this cancer to enhance the diagnostics options and expand the treatment.

Among regions, the most impacted and higher cases of prostate cancer are the North American region, followed by European and Asia-Pacific regions. COVID-19 pandemic has transformed the market landscape. It has impacted almost every sector across the nations due to restrictions, lockdowns, and bard on transportation. Many surgeries have been postponed because of this pandemic. And as per our study, there would be a surge in this market post-pandemic recovery. As per this research report, Global Prostate Cancer Diagnostics Industry is expected to grow with a double-digit staggering CAGR of 24.69% during 2020-2027.

Renub Research latest report "Prostate Cancer Diagnostics Market Global Forecast by Diagnosis Type (Preliminary Screening Test, Confirmatory Test, PCA3, Trans-rectal Ultrasound, Biopsy), End Users (Hospitals & Clinics, Diagnostics Centers, Research Institute, Others), Regions - North America & Latin America (United States, Canada, Rest of America), Europe (Norway, Italy, Poland, Germany, United Kingdom, Rest of Europe), Asia (China, India, Rest of Asia), Africa (South Africa, Rest of Africa), Company Analysis (GSK, AstraZeneca, Sanofi, Abbott, Pfizer)" provides a complete analysis of Prostate Cancer Diagnostics Industry"

Diagnosis Type - Market breakup from 5 viewpoints

1. Preliminary Screening Test

2. Confirmatory Test

3. PCA3

4. Trans-rectal Ultrasound

5. Biopsy

End-Users - Market breakup from 4 viewpoints

1. Hospitals& Clinics

2. Diagnostic Centers

3. Research institute

4. Others

Regions - Market breakup by Countries

North America & Latin America

  • United States
  • Canada
  • Rest of America

Europe

  • Norway
  • Italy
  • Poland
  • Germany
  • United Kingdom
  • Rest OF Europe

Asia

  • China
  • India
  • Rest of Asia

Africa

  • South Africa
  • Rest of Africa

All companies have been covered with 3 viewpoints

  • Overviews
  • Recent Developments
  • Revenues

Company Analysis

1. GSK

2. AstraZeneca

3. Sanofi

4. Abbott

5. Pfizer

Table of Contents

1. Introduction

2. Research & Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Prostate Cancer Diagnostic Market

6. Market Share Analysis

  • 6.1 Diagnosis Type
  • 6.2 Confirmatory Test
  • 6.3 End-User
  • 6.4 Regions

7. Diagnosis Type - Global Prostate Cancer Diagnostics Market

  • 7.1 Preliminary Screening Test
  • 7.2 Confirmatory Test
  • 7.3 PCA3
  • 7.4 Trans-rectal Ultrasound
  • 7.5 Biopsy

8. End-User - Global Prostate Cancer Diagnostics Market

  • 8.1 Hospitals & Clinics
  • 8.2 Diagnostic Centers
  • 8.3 Research institute
  • 8.4 Others

9. Regions - Global Prostate Cancer Diagnostics Market

  • 9.1 North America & Latin America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Rest of America
  • 9.2 Europe
    • 9.2.1 Norway
    • 9.2.2 Italy
    • 9.2.3 Poland
    • 9.2.4 Germany
    • 9.2.5 United Kingdom
    • 9.2.6 Rest OF Europe
  • 9.3 Asia
    • 9.3.1 China
    • 9.3.2 India
    • 9.3.3 Rest of Asia
  • 9.4 Africa
    • 9.4.1 South Africa
    • 9.4.2 Rest of Africa

10. Company Analysis

  • 10.1 GSK
    • 10.1.1 Overviews
    • 10.1.2 Recent Developments
    • 10.1.3 Revenues
  • 10.2 AstraZeneca
    • 10.2.1 Overviews
    • 10.2.2 Recent Developments
    • 10.2.3 Revenues
  • 10.3 Sanofi
    • 10.3.1 Overviews
    • 10.3.2 Recent Developments
    • 10.3.3 Revenues
  • 10.4 Abbott
    • 10.4.1 Overviews
    • 10.4.2 Recent Developments
    • 10.4.3 Revenues
  • 10.5 Pfizer
    • 10.5.1 Overviews
    • 10.5.2 Recent Developments
    • 10.5.3 Revenues

List of Figures

Figure-01: Global - Global Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-02: Global - Forecast for Global Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-03: Type - Preliminary Screening Test Market (Million US$), 2017 - 2020

Figure-04: Type - Forecast for Preliminary Screening Test Market (Million US$), 2021 - 2027

Figure-05: Type - Confirmatory Test Market (Million US$), 2017 - 2020

Figure-06: Type - Forecast for Confirmatory Test Market (Million US$), 2021 - 2027

Figure-07: Type - PCA3 Test Market (Million US$), 2017 - 2020

Figure-08: Type - Forecast for PCA3 Test Market (Million US$), 2021 - 2027

Figure-09: Type - Trans-rectal Ultrasound Test Market (Million US$), 2017 - 2020

Figure-10: Type - Forecast for Trans-rectal Ultrasound Test Market (Million US$), 2021 - 2027

Figure-11: Type - Biopsy Test Market (Million US$), 2017 - 2020

Figure-12: Type - Forecast for Biopsy Test Market (Million US$), 2021 - 2027

Figure-13: By User - Hospitals& Clinics Market (Million US$), 2017 - 2020

Figure-14: By User - Forecast for Hospitals& Clinics Market (Million US$), 2021 - 2027

Figure-15: By User - Diagnostic Centers Market (Million US$), 2017 - 2020

Figure-16: By User - Forecast for Diagnostic Centers Market (Million US$), 2021 - 2027

Figure-17: By User - Research Institute Market (Million US$), 2017 - 2020

Figure-18: By User - Forecast for Research Institute Market (Million US$), 2021 - 2027

Figure-19: By User - Others Prostate Cancer Market (Million US$), 2017 - 2020

Figure-20: By User - Forecast for Others Prostate Cancer Market (Million US$), 2021 - 2027

Figure-21: By Region - North America & Latin America Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-22: By Region - Forecast for North America & Latin America Prostate Diagnostic Market (Million US$), 2021 - 2027

Figure-23: By Country - United States Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-24: By Region - Forecast for United States Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-25: By Country - Canada Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-26: By Country - Forecast for Canada Prostate CancerDiagnostic Market (Million US$), 2021 - 2027

Figure-27: By Country - Rest of America Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-28: By Country - Forecast for Rest of America Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-29: By Region - Europe Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-30: By Region - Forecast for Europe Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-31: By Country - Norway Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-32: By Country - Forecast for Norway Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-33: By Country - Italy Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-34: By Country - Forecast for Italy Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-35: By Country - Poland Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-36: By Country - Forecast for Poland Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-37: By Country - Germany Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-38: By Country - Forecast for Germany Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-39: By Country - United Kingdom Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-40: By Country - Forecast for United Kingdom Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-41: By Country - Rest of Europe Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-42: By Country - Forecast for Rest of Europe Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-43: By Region - Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-44: By Region - Forecast for Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-45: By Country - China Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-46: By Country - Forecast for China Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-47: By Country - India Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-48: By Country - Forecast for India Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-49: By Country - Rest of Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-50: By Country - Forecast for Rest of Asia Pacific Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-51: By Region - Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-52: By Region - Forecast for Africa Prostate Diagnostic Market (Million US$), 2021 - 2027

Figure-53: By Country - South Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-54: By Country - Forecast for South Africa Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-55: By Country - Rest of Africa Prostate Cancer Diagnostic Market (Million US$), 2017 - 2020

Figure-56: By Country - Forecast for Rest of Africa Prostate Cancer Diagnostic Market (Million US$), 2021 - 2027

Figure-57: GSK - Global Revenue (Million US$), 2015 - 2020

Figure-58: GSK - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-59: AstraZeneca - Global Revenue (Million US$), 2015 - 2020

Figure-60: AstraZeneca - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-61: Sanofi - Global Revenue (Million US$), 2015 - 2020

Figure-62: Sanofi - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-63: Abbott - Global Revenue (Million US$), 2015 - 2020

Figure-64: Abbott - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-65: Pfizer - Global Revenue (Million US$), 2015 - 2020

Figure-66: Pfizer - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-67: Siemens Healthcare GMBH - Global Revenue (Million US$), 2015 - 2020

Figure-68: Siemens Healthcare GMBH - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-69: BioMerieux - Global Revenue (Million US$), 2015 - 2020

Figure-70: BioMerieux - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-71: Hologic, Inc - Global Revenue (Million US$), 2015 - 2020

Figure-72: Hologic, Inc - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-73: MDX Healthcare - Global Revenue (Million US$), 2015 - 2020

Figure-74: MDX Healthcare - Forecast for Global Revenue (Million US$), 2021 - 2027

Figure-75: Myriad Genetics - Global Revenue (Million US$), 2015 - 2020

Figure-76: Myriad Genetics - Forecast for Global Revenue (Million US$), 2021 - 2027